Yunovia Pronounces IND Approval by the MFDS to Provoke Section 1 MAD Examine for the Small Molecule GLP-1 Agonist By Investing.com
SEOUL, South Korea, Aug. 27, 2024 /PRNewswire/ -- Yunovia, a drug R&D…
Search
Have an existing account?
Sign In
